References
- Prendergast GC, Jaffee EM. Cancer immunologists and cancer biologists: why we didn’t talk then but need to now. Cancer Res 2007; 67:3500 - 4; http://dx.doi.org/10.1158/0008-5472.CAN-06-4626; PMID: 17413003
- Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, Hibbert L, Churakova T, Travis M, Vaisberg E, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002; 16:779 - 90; http://dx.doi.org/10.1016/S1074-7613(02)00324-2; PMID: 12121660
- Garbers C, Hermanns HM, Schaper F, Müller-Newen G, Grötzinger J, Rose-John S, Scheller J. Plasticity and cross-talk of interleukin 6-type cytokines. Cytokine Growth Factor Rev 2012; 23:85 - 97; http://dx.doi.org/10.1016/j.cytogfr.2012.04.001; PMID: 22595692
- Liu X, Wang Z, Ye N, Chen Z, Zhou X, Teng X, Huang N, Liu N, Zhang N, Guan T, et al. A protective role of IL-30 via STAT and ERK signaling pathways in macrophage-mediated inflammation. Biochem Biophys Res Commun 2013; 435:306 - 12; http://dx.doi.org/10.1016/j.bbrc.2013.03.136; PMID: 23583238
- Di Meo S, Airoldi I, Sorrentino C, Zorzoli A, Esposito S, Di Carlo E. Interleukin-30 expression in prostate cancer and its draining lymph nodes correlates with advanced grade and stage. Clin Cancer Res 2013; Forthcoming http://dx.doi.org/10.1158/1078-0432.CCR-13-2240; PMID: 24277453
- Di Carlo E, D’Antuono T, Pompa P, Giuliani R, Rosini S, Stuppia L, Musiani P, Sorrentino C. The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance. Clin Cancer Res 2009; 15:2979 - 87; http://dx.doi.org/10.1158/1078-0432.CCR-08-1951; PMID: 19366834
- Garbers C, Spudy B, Aparicio-Siegmund S, Waetzig GH, Sommer J, Hölscher C, Rose-John S, Grötzinger J, Lorenzen I, Scheller J. An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimer. J Biol Chem 2013; 288:4346 - 54; http://dx.doi.org/10.1074/jbc.M112.432955; PMID: 23209286
- Hobisch A, Rogatsch H, Hittmair A, Fuchs D, Bartsch G Jr., Klocker H, Bartsch G, Culig Z. Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue. J Pathol 2000; 191:239 - 44; http://dx.doi.org/10.1002/1096-9896(2000)9999:9999<::AID-PATH633>3.0.CO;2-X; PMID: 10878544
- Wang Y, Li J, Cui Y, Li T, Ng KM, Geng H, Li H, Shu XS, Li H, Liu W, et al. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. Cancer Res 2009; 69:5194 - 201; http://dx.doi.org/10.1158/0008-5472.CAN-08-3694; PMID: 19509237
- Bondue B, Wittamer V, Parmentier M. Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine Growth Factor Rev 2011; 22:331 - 8; http://dx.doi.org/10.1016/j.cytogfr.2011.11.004; PMID: 22119008